TGFB1 and glomerulosclerosis: Early human clinical studies have demonstrated the increased expression of TGF-β ligands in diseased kidneys, and numerous experimental studies have shown the causal link of TGF-β in inducing glomerulosclerosis and tubulointerstitial fibrosis.